💊 Big Pharma is making big moves. Vertex Pharmaceuticals just announced a ~$10B all-cash acquisition of Crinetics — its largest deal ever, signaling a major shift beyond its core cystic fibrosis business. 📊 Key highlights: • $85/share offer — ~102% premium • Expands into rare endocrine diseases • Adds approved drug + late-stage pipeline • Potential >$5B peak annual revenue 📉 Market reaction: Crinetics surged ~100% overnight Vertex dipped slightly — a typical response to large acquisitions ✨ Follow us for more latest updates! #KVB# #TradingNews #Biotech #StockMarket #Investing #MergersAndAcquisitions